RESMED INC — Director's Dealing 2017

Jun 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-06-01

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-01	ResMed Common Stock Options	$71.89	A	6982	Acquired	2024-06-01	ResMed Common Stock (6982)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	78112	Direct

Footnotes

F1: Includes 216 shares of ResMed stock purchased on April 28, 2017, through the ResMed Employee Stock Purchase Plan.

F2: Represents date options first become exercisable. Options vest 1/3 annually each June 1, 2018, 2019 and 2020.